Legence Corp. Class A Common stock
LGN
$70.04
+5.52%
Legence Corp is a provider of engineering, installation, and maintenance services for critical building systems, focusing on sectors with technically demanding facilities such as technology, life sciences, healthcare, and education. The company designs, fabricates, and installs complex HVAC, process piping, and other MEP systems, and also upgrades existing buildings for enhanced performance and efficiency. As a specialized player in the Engineering & Construction industry, Legence differentiates itself through its expertise in critical infrastructure and its fixed-price service model. The current investor narrative centers on the company's rapid growth since its September 2025 IPO, driven by strong demand for its services and a recent $24 million institutional investment, which has fueled an 80% stock surge and heightened market confidence in its role in critical infrastructure build-outs.…
LGN
Legence Corp. Class A Common stock
$70.04
Related headlines
Investment Opinion: Should I buy LGN Today?
Based on the strong analyst consensus (Strong Buy, mean rating 1.24) and the average target price of $105.71, which implies 59.3% upside, we rate LGN as a Buy. The thesis is driven by the company's exceptional revenue growth of 105.1% YoY and the positive earnings inflection, which suggest a scalable business model. The price-to-sales ratio of 1.00x is below the industry average, offering a potential discount, and the forward PE of 34.5x, while high, reflects expectations of significant EPS growth to $3.06. The company's free cash flow of $297.1M provides financial flexibility, and the recent $24M institutional investment signals confidence. However, the rating is contingent on the company maintaining its growth trajectory and improving margins. If gross margins fail to recover above 20% or revenue growth decelerates below 50%, the thesis would be invalidated, and we would downgrade to Hold. Conversely, if margins expand and the company beats estimates, the stock could move toward the high target of $125. Overall, LGN appears undervalued relative to its growth potential, but investors should monitor execution closely.
Sign up to view all
LGN 12-Month Price Forecast
The AI assessment leans bullish given the exceptional revenue growth and improving profitability, which are supported by strong analyst sentiment. However, the high leverage and thin margins introduce uncertainty, and the forward PE of 34.5x leaves little room for error. The stance would be upgraded to high confidence if the company demonstrates sustained margin expansion and continued revenue acceleration in the next two quarters. Conversely, a downgrade to neutral would occur if revenue growth decelerates below 50% or if the company reports a loss in Q2 2026.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Legence Corp. Class A Common stock's 12-month outlook, with a consensus price target around $103.00 and implied upside of +47.1% versus the current price.
Average Target
$103.00
0 analysts
Implied Upside
+47.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$80 - $125
Analyst target range
Analyst coverage is robust with 17 analysts, and the consensus recommendation is a Strong Buy, with a mean rating of 1.24 (where 1 is Strong Buy and 5 is Sell). The average target price is $105.71, implying a 59.3% upside from the current price of $66.375, while the low and high targets are $80.00 and $125.00, respectively. The wide range between low and high targets (56.3% spread) indicates significant uncertainty about the company's future performance, but the strong buy consensus and recent upgrades from firms like Guggenheim and BMO Capital suggest analysts are optimistic about Legence's growth prospects.
Bulls vs Bears: LGN Investment Factors
Legence presents a compelling growth story with explosive revenue growth, strong analyst support, and improving profitability, but faces significant challenges from thin margins, high leverage, and a demanding valuation. The bull case is currently stronger, driven by the 105% revenue growth and the positive earnings inflection, which suggest the company is executing well. However, the key tension lies in whether the company can sustain its growth while improving margins to justify the forward PE of 34.5x. If margins expand and growth continues, the stock could re-rate higher; if not, the high leverage and valuation could lead to a sharp correction.
Bullish
- Explosive Revenue Growth: Q1 2026 revenue surged 105.1% YoY to $1.038B, with sequential growth from $737.6M in Q4 2025, indicating accelerating demand for critical building systems. This rapid expansion underscores strong market traction and a robust pipeline.
- Strong Analyst Conviction: With 17 analysts, the consensus is a Strong Buy (mean rating 1.24) and an average target price of $105.71, implying 59.3% upside from the current $66.375. Recent upgrades from Guggenheim and BMO Capital reinforce positive sentiment.
- Attractive Valuation on Sales: The price-to-sales ratio stands at 1.00x, below the industry average, suggesting the market is not fully pricing in the growth trajectory. This discount provides a margin of safety if revenue growth continues.
- Positive Earnings Inflection: Q1 2026 marked a turnaround to positive EPS of $0.24 and net income of $16.1M, a significant improvement from the -$0.55 EPS in Q4 2025. This demonstrates improving operational efficiency and a path to sustained profitability.
Bearish
- Thin Gross Margins: Gross margin in Q1 2026 was only 14.4%, down from 20.0% in Q4 2025, reflecting cost-intensive operations and potential pricing pressure. Such low margins leave little room for error and amplify the impact of cost overruns.
- High Debt-to-Equity: Debt-to-equity ratio is 2.43, indicating significant leverage. With interest expenses of $17M in Q1 2026, the company is exposed to rising interest rates, which could pressure profitability and limit financial flexibility.
- Negative Net Margin: Despite positive net income in Q1, the trailing net margin is -2.3%, and the company has a history of losses. This suggests that profitability is not yet stable and could be volatile as the company scales.
- High Valuation on Forward Earnings: The forward PE of 34.5x implies high growth expectations. If the company fails to meet EPS estimates of $3.06, the stock could face significant de-rating, especially given the recent volatility.
LGN Technical Analysis
Legence's stock has exhibited a volatile yet strongly upward long-term trend since its IPO, with a 1-year price change of +48.6% YTD and a 6-month change of +38.9%. The current price of $66.375 sits at 49.5% of its 52-week range (low $26.96, high $107.238), indicating a mid-range position after a significant pullback from its highs. This positioning suggests the stock is neither overextended nor at a clear value point, reflecting a market that is reassessing after a rapid run-up.
Beta
—
—
Max Drawdown
-48.1%
Largest decline past year
52-Week Range
$27-$107
Price range past year
Annual Return
—
Cumulative gain past year
| Period | LGN Return | S&P 500 |
|---|---|---|
| 1m | +2.6% | +4.0% |
| 3m | -12.9% | +5.3% |
| 6m | +50.2% | +12.6% |
| 1y | — | +20.1% |
| ytd | +56.8% | +13.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LGN Fundamental Analysis
Revenue has grown robustly, with the most recent quarter (Q1 2026) reporting $1.0379 billion, a 105.1% YoY increase, and sequential growth from $737.6 million in Q4 2025. The Installation and Maintenance segment drives the majority of revenue at $872.1 million, while Engineering and Consulting contributes $165.8 million. This growth trajectory indicates accelerating demand, though the company's profitability remains challenged, with a net margin of -2.3% and a gross margin of 14.4% in Q1 2026, reflecting the cost-intensive nature of the business.
Quarterly Revenue
$1.0B
2026-03
Revenue YoY Growth
+105.1%
YoY Comparison
Gross Margin
14.4%
Latest Quarter
Free Cash Flow
$297126000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LGN Overvalued?
Given the negative trailing EPS of -$0.023, the price-to-sales ratio is the primary valuation metric, currently at 1.00x, which is below the industry average, suggesting a potential discount. The forward PE of 34.5x implies the market expects significant earnings growth, as analysts project EPS of $3.06 for the next fiscal year. This gap between trailing and forward metrics indicates optimism about future profitability, but also highlights the risk if growth fails to materialize.
PE
-42.6x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
33.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Legence carries a high debt-to-equity ratio of 2.43, which amplifies the impact of its $17M quarterly interest expense. The company's gross margin of 14.4% is thin, leaving little buffer for cost overruns or project delays, and the negative trailing net margin of -2.3% indicates that profitability is not yet consistent. While Q1 2026 showed a positive EPS of $0.24, the company has a history of losses, and the reliance on fixed-price contracts exposes it to execution risk. The current ratio of 1.57 provides some liquidity, but the high leverage could strain cash flows if growth slows or interest rates rise.
FAQ
The key risks include: 1) Financial risk from high debt-to-equity of 2.43 and thin gross margins of 14.4%, which could lead to cash flow strain. 2) Market risk from valuation compression if the company fails to meet high growth expectations, as the forward PE of 34.5x leaves little room for error. 3) Competitive risk from larger, more established players in the engineering and construction industry. 4) Macro risk from interest rate hikes, which would increase debt costs and potentially slow infrastructure spending. The most severe risk is a combination of margin compression and a growth slowdown, which could lead to a significant de-rating.
The 12-month forecast is bullish, with a base case probability of 45% targeting $85-$105, a bull case probability of 35% targeting $105-$125, and a bear case probability of 20% targeting $50-$80. The most likely scenario is the base case, which assumes continued revenue growth of around 70-80% and stable margins. The average analyst target of $105.71 implies a 59.3% upside from the current price. However, the wide range between the low ($80) and high ($125) targets reflects significant uncertainty, and investors should monitor quarterly earnings closely.
On a price-to-sales basis, LGN appears undervalued at 1.00x, below the industry average. However, the forward PE of 34.5x suggests the market expects substantial earnings growth, which could be justified if the company meets its EPS estimate of $3.06. The PEG ratio of 0.037 is extremely low, indicating that the stock is undervalued relative to its growth rate. Overall, the valuation is mixed: it is cheap on sales and growth-adjusted earnings, but expensive on forward earnings, implying that the market is pricing in a successful execution of the growth plan.
LGN presents a compelling risk/reward opportunity, with analysts seeing 59.3% upside to the average target of $105.71. The stock's price-to-sales ratio of 1.00x is below the industry average, suggesting it is not overvalued on a sales basis. However, the high forward PE of 34.5x and negative trailing net margin indicate that the market is pricing in significant future growth. For investors with a high risk tolerance and a belief in the company's growth story, LGN could be a good buy, but it is not suitable for conservative investors. The biggest downside risk is a failure to meet growth expectations, which could lead to a sharp de-rating.
LGN is better suited for long-term investment, given its high growth potential and the early stage of its profitability turnaround. The stock has a beta that indicates high volatility, with a max drawdown of -48.1%, making it unsuitable for short-term trading unless one has a high risk tolerance. The company's growth trajectory, driven by critical infrastructure demand, suggests that a holding period of at least 3-5 years would allow the company to mature and potentially deliver substantial returns. Short-term investors may find the volatility too risky, as the stock has experienced significant swings in recent months.